What is the incidence of bleeding complications in patients undergoing angioplasty while on anticoagulation therapy?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The evidence suggests a 3-5% incidence rate of major bleeding in patients undergoing angioplasty on anticoagulation therapy, with dual antithrombotic therapies, especially involving NOACs, showing the potential for reduced bleeding risk compared to triple therapy regimens.

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Coronary Interventions and Diagnostics Atrial Fibrillation Management and Outcomes

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN